share_log

8-K: Current report

SEC announcement ·  Apr 18 08:21
Summary by Moomoo AI
On April 12, 2024, SeaStar Medical Holding Corporation, a company listed on NASDAQ under the trading symbol ICU, announced amendments to its corporate bylaws. The Board of Directors approved the Second Amended and Restated Bylaws, which included significant changes such as the reduction of the quorum threshold for stockholder meetings from a majority to at least 33 1/3% of the common stock issued and outstanding. Additionally, the amendments removed the definition and provisions related to 'Acting in Concert' from the bylaws, affecting how a Proposing Stockholder is identified. These changes are detailed in Exhibit 3.1 attached to the Form 8-K filed with the SEC. The company, identified as an emerging growth company, has made these amendments to streamline its governance processes. The full text of the amended bylaws is incorporated by reference into the report and is available for review.
On April 12, 2024, SeaStar Medical Holding Corporation, a company listed on NASDAQ under the trading symbol ICU, announced amendments to its corporate bylaws. The Board of Directors approved the Second Amended and Restated Bylaws, which included significant changes such as the reduction of the quorum threshold for stockholder meetings from a majority to at least 33 1/3% of the common stock issued and outstanding. Additionally, the amendments removed the definition and provisions related to 'Acting in Concert' from the bylaws, affecting how a Proposing Stockholder is identified. These changes are detailed in Exhibit 3.1 attached to the Form 8-K filed with the SEC. The company, identified as an emerging growth company, has made these amendments to streamline its governance processes. The full text of the amended bylaws is incorporated by reference into the report and is available for review.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Doc 2

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more